The most common ophthalmic procedure is an intravitreal injection, with more than 10 million per year performed in the U.S.
These injections of anti-VEGF and corticosteroid medications are helpful in treating retinal disease and inflammation. For the vast majority of patients, these intravitreal injections are easy, painless and beneficial; however, there can be rare complications, such as infection. Another potential complication is iatrogenic damage to the crystalline lens capsule during the injection.
During the cataract consultation, patients with a history of intravitreal injections should